Delta Asset Management’s Integra LifeSciences IART Stock Holding History

Delta Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200	Closed	-$13K	–	593
2020 Q4	$13K	Hold	200	–	–	﹤0.01%	384
2020 Q3	$9K	Hold	200	–	–	﹤0.01%	412
2020 Q2	$9K	Sell	200 -27	-12%	-$1.33K	﹤0.01%	415
2020 Q1	$10K	Hold	227	–	–	﹤0.01%	392
2019 Q4	$13K	Hold	227	–	–	﹤0.01%	406
2019 Q3	$14K	Buy	+227	New	+$13.5K	﹤0.01%	383
2018 Q1	–	Sell	-34	Closed	-$2K	–	685
2017 Q4	$2K	Hold	34	–	–	﹤0.01%	592
2017 Q3	$2K	Buy	+34	New	+$1.75K	﹤0.01%	566

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Delta Asset Management's IART Position: Q1 2021 in Review

Delta Asset Management sold out of Integra LifeSciences (IART) in Q1 2021, closing a stake of 200 shares — an estimated $13K sold.

Delta Asset Management first reported a position in IART in Q3 2017 and held it in 8 quarters. The position peaked at $14K in Q3 2019. 257 funds tracked by Wall St. Rank hold IART as of Q1 2021.

Delta Asset Management reported no remaining Integra LifeSciences position as of Q1 2021 after selling out during the quarter.
Delta Asset Management sold 200 Integra LifeSciences shares in Q1 2021, an estimated $13K.
Delta Asset Management first reported a position in Integra LifeSciences in Q3 2017 and held it in 8 quarters.
Delta Asset Management's Integra LifeSciences position peaked at $14K in Q3 2019.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2021.

Based on Delta Asset Management's 13F filing for Q1 2021, filed 28 Apr 2021.